Company record
Burlington Medical, LLC
0 FDA warning letters since 2023 and 13 recalls in the last 12 months.
Get an email the day FDA posts anything new about Burlington Medical, LLC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Apr 8 | Class II | Burlington Medical, LLC Device |
Burlington Medical, Wrap Aprons. Potential for attenuation degradation over time, decreasing the lifespan. FDA notice Z-1757-2026 |
| Apr 8 | Class II | Burlington Medical, LLC Device |
Burlington Medical, Leg Wraps. Potential for attenuation degradation over time, decreasing the lifespan. FDA notice Z-1761-2026 |
| Apr 8 | Class II | Burlington Medical, LLC Device |
Burlington Medical, Half Aprons. Potential for attenuation degradation over time, decreasing the lifespan. FDA notice Z-1762-2026 |
| Apr 8 | Class II | Burlington Medical, LLC Device |
Burlington Medical, Vest Potential for attenuation degradation over time, decreasing the lifespan. FDA notice Z-1754-2026 |
| Apr 8 | Class II | Burlington Medical, LLC Device |
Burlington Medical, Demi Half Aprons. Potential for attenuation degradation over time, decreasing the lifespan. FDA notice Z-1763-2026 |
| Apr 8 | Class II | Burlington Medical, LLC Device |
Burlington Medical, Kilt Blockers. Potential for attenuation degradation over time, decreasing the lifespan. FDA notice Z-1765-2026 |
| Apr 8 | Class II | Burlington Medical, LLC Device |
Burlington Medical, Protective Sleeves. Potential for attenuation degradation over time, decreasing the lifespan. FDA notice Z-1759-2026 |
| Apr 8 | Class II | Burlington Medical, LLC Device |
Burlington Medical, Frontal Aprons Potential for attenuation degradation over time, decreasing the lifespan. FDA notice Z-1756-2026 |
| Apr 8 | Class II | Burlington Medical, LLC Device |
Burlington Medical, Blockers. Potential for attenuation degradation over time, decreasing the lifespan. FDA notice Z-1764-2026 |
| Apr 8 | Class II | Burlington Medical, LLC Device |
Burlington Medical, Thyroid Shield. Potential for attenuation degradation over time, decreasing the lifespan. FDA notice Z-1753-2026 |
| Apr 8 | Class II | Burlington Medical, LLC Device |
Burlington Medical, Caps. Potential for attenuation degradation over time, decreasing the lifespan. FDA notice Z-1760-2026 |
| Apr 8 | Class II | Burlington Medical, LLC Device |
Burlington Medical, Kilt Potential for attenuation degradation over time, decreasing the lifespan. FDA notice Z-1755-2026 |
| Apr 8 | Class II | Burlington Medical, LLC Device |
Burlington Medical, BAT (Breast, Axilla and Thyroid) Coverage. Potential for attenuation degradation over time, decreasing the lifespan. FDA notice Z-1758-2026 |